Acquity UPLC I-Class Plus

The Food and Drug Administration is forecasting the acquisition of Acquity UPLC I-Class Plus instrumentation to enhance analytical capabilities across four laboratories focused on detecting undeclared and nonpermitted color additives in regulated products. This equipment will support a strategic shift toward more sensitive and high-throughput detection methods, improving the agency’s ability to ensure product safety and regulatory compliance. The procurement is associated with NAICS code 334516 and is being managed by the FDA, with program coordination handled by the Hfp Acquisition Liaison at hfpacquisitions@fda.hhs.gov. The contracting officer position has not yet been filled, and no specific delivery location or set-aside details are provided. This forecast indicates an upcoming opportunity for vendors to prepare responses as the formal solicitation process advances.